Literature DB >> 24969700

Effects of glucocorticoids in potentiating diuresis in heart failure patients with diuretic resistance.

Chao Liu1, Kunshen Liu2.   

Abstract

Diuretic resistance in heart failure is defined as a state in which diuretic response is diminished or lost before the therapeutic goal of relief from congestion has been reached. Diuretic resistance is very common and is associated with poor outcomes. Over the past decade, several new drugs and devices targeting decongestion and improvement in renal function in patients with heart failure have failed to show benefit in randomized clinical trials. Glucocorticoids had been used to manage diuretic resistance before the advent of loop diuretics. More recent evidence appears to confirm that glucocorticoids may also help to overcome resistance to loop diuretics. This review tries to summarize the available evidence and potential mechanisms related to glucocorticoid therapy in patients with heart failure and its effect on diuretic resistance.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure; diuretic resistance; glucocorticoids

Mesh:

Substances:

Year:  2014        PMID: 24969700     DOI: 10.1016/j.cardfail.2014.06.353

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  8 in total

Review 1.  Glucocorticoids and programming of the microenvironment in heart.

Authors:  Rui Song; Xiang-Qun Hu; Lubo Zhang
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

Review 2.  Inpatient Diuretic Management of Acute Heart Failure: A Practical Review.

Authors:  Saif Ali; Sharon Jung; Shuktika Nandkeolyar; Liset Stoletniy; Antoine Sakr; Frederik H Verbrugge; Anthony Hilliard; Dmitry Abramov
Journal:  Am J Cardiovasc Drugs       Date:  2021-03-12       Impact factor: 3.571

3.  Depression is associated with increased C-reactive protein levels in patients with heart failure and hyperuricemia.

Authors:  Yu Wang; Yu-Zhi Zhen; Jian-Long Zhai; Dan Wu; Kun-Shen Liu; Qing-Zhen Zhao; Chao Liu
Journal:  J Geriatr Cardiol       Date:  2017-04       Impact factor: 3.327

Review 4.  Hormone treatments in congestive heart failure.

Authors:  Lei Lei; Yuanjie Mao
Journal:  J Int Med Res       Date:  2018-02-22       Impact factor: 1.671

5.  [Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure].

Authors:  C S Kow; D S Ramachandram; S S Hasan
Journal:  Rev Clin Esp       Date:  2021-11-20       Impact factor: 3.064

6.  The Impact of Glucocorticoid Therapy on Guideline-Directed Medical Treatment Titration in Patients Hospitalized for Heart Failure with Low Blood Pressure: A Retrospective Study.

Authors:  Shuyu Li; Qingzhen Zhao; Yuzhi Zhen; Lizhuo Li; Yiqing Mi; Tongxin Li; Kunshen Liu; Chao Liu
Journal:  Int J Gen Med       Date:  2021-10-12

7.  Glucocorticoids Reverse Diluted Hyponatremia Through Inhibiting Arginine Vasopressin Pathway in Heart Failure Rats.

Authors:  Xiaoran Zhu; Yaomeng Huang; Shuyu Li; Ning Ge; Tongxin Li; Yu Wang; Kunshen Liu; Chao Liu
Journal:  J Am Heart Assoc       Date:  2020-05-09       Impact factor: 5.501

8.  Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure.

Authors:  C S Kow; D S Ramachandram; S S Hasan
Journal:  Rev Clin Esp (Barc)       Date:  2022-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.